Drug recall · September 30, 2026
Exenatide Injection recall
Why: Defective Delivery System: Possibility of no medication in the prefilled pen.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
- Lots / codes
Lot #: AP250095A, Exp 2/28/2027
- Quantity
- 5,694 pens
- Company
- Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY
- Distribution
- USA Nationwide
- Initiated
- August 28, 2026 · Voluntary: Firm initiated
- Classified
- September 22, 2026
- Reported
- September 30, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Exenatide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.